Charles River Laboratories International, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Charles River Laboratories International, Inc. (CRL) is 19.60B

According to Charles River Laboratories International, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.60B. This represents a change of 68.41% compared to the average of 11.64B of the last 4 quarters.

Charles River Laboratories International, Inc. (CRL) Historical Enterprise Value (quarterly & annually)

How has CRL Enterprise Value performed in the past?

The mean historical Enterprise Value of Charles River Laboratories International, Inc. over the last ten years is 11.71B. The current 19.60B Enterprise Value has changed 67.36% with respect to the historical average. Over the past ten years (40 quarters), CRL's Enterprise Value was at its highest in in the September 2021 quarter at 26.07B. The Enterprise Value was at its lowest in in the December 2016 quarter at 4.71B.

Charles River Laboratories International, Inc. (CRL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Charles River Laboratories International, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Charles River Laboratories International, Inc. (CRL) Average Enterprise Value

How has CRL Enterprise Value performed in the past?

The current Enterprise Value of Charles River Laboratories International, Inc. (CRL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Charles River Laboratories International, Inc. (CRL) Enterprise Value vs. Peers

How is CRL’s Enterprise Value compared to its peers?

Charles River Laboratories International, Inc.’s Enterprise Value is greater than Medpace Holdings, Inc. (17.53B), greater than ICON Public Limited Company (18.52B), less than WuXi AppTec Co., Ltd. (314.31B), less than Joinn Laboratories(China)Co.,Ltd. (29.81B), less than Pharmaron Beijing Co., Ltd. (67.50B), less than WuXi Biologics (Cayman) Inc. (149.33B), less than WuXi XDC Cayman Inc (69.78B), greater than Genscript Biotech Corporation (10.29B), less than Hangzhou Tigermed Consulting Co., Ltd (36.35B), greater than Certara, Inc. (1.77B),

Build a custom stock screener for Charles River Laboratories International, Inc. (CRL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Charles River Laboratories International, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Charles River Laboratories International, Inc. (CRL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Charles River Laboratories International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.